Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Tuesday, February 26, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Feb. 25, 2019 /PRNewswire/ -- Global Hepatitis Therapeutics Market: OverviewThis report analyzes the current

and future scenario of the global hepatitis therapeutics market. Increase in the prevalence of viral hepatitis, promising hepatitis drug pipeline, and favorable government support are the major drivers of the global market.Read the full report: https://www.reportlinker.com/p05743505 The
global hepatitis therapeutics market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to segments based on disease type, drug class, distribution channel, and region.A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises company profiles with product portfolio to understand the competitive landscape in the market.This section of the report also provides market attractiveness analysis, by region, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global hepatitis therapeutics market.Global Hepatitis Therapeutics Market: Key SegmentsThe global hepatitis therapeutics market has been segmented based on disease type, drug class, distribution channel, and region.In terms of disease type, the global market has been segmented into hepatitis A, hepatitis B, hepatitis C, and others.Based on drug class, the global hepatitis therapeutics market has been categorized into nucleotide analog reverse transcriptase inhibitor, NS5A inhibitor, multi- class combination, nucleotide analog NS5B polymerase inhibitor, interferon & ribavirin, and others.Based on distribution channel, the global market has been divided into hospital pharmacies, retail pharmacies, and others.The market value and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.Global Hepatitis Therapeutics Market: Regional OutlookThe global hepatitis therapeutics market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The Market Value and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.Companies Mentioned in ReportThe report also profiles major players in the global hepatitis therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, recent developments, and SWOT analysis. Major companies profiled in the report are Bristol Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc., F. Hoffmann-La Roche, Ltd., LAURUS Labs, AbbVie Inc., Hetero Healthcare Limited, Zydus Cadila, Cipla, Inc., and NATCO Pharma Limited.The global hepatitis therapeutics market has been segmented as below:Global Hepatitis Therapeutics Market, by DiseaseHepatitis AHepatitis BHepatitis COthersGlobal Hepatitis Therapeutics Market, by Drug ClassNucleotide Analog Reverse Transcriptase InhibitorNS5A InhibitorMulti Class CombinationNucleotide Analog NS5B Polymerase InhibitorInterferon & RibavirinOthersGlobal Hepatitis Therapeutics Market, by Distribution ChannelHospital PharmaciesRetail PharmaciesOnline PharmaciesGlobal Hepatitis Therapeutics Market, by RegionNorth AmericaU.S.CanadaEuropeGermanyU.K.FranceSpainItalyRest of EuropeAsia PacificIndiaChinaJapanAustralia & New ZealandRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaGCC CountriesSouth AfricaRest of Middle East & AfricaRead the full report: https://www.reportlinker.com/p05743505 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/hepatitis-therapeutics-market---global-industry-analysis-size-share-growth-trends-and-forecast-2018---2026-300801316.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store